The New York-headquartered biopharmaceutical giant paid the DOJ and SEC $60 million in 2012 to settle FCPA offenses in Bulgaria, Croatia, China, Czech Republic, Italy, Kazakhstan, Russia, Serbia, Indonesia, Pakistan, and Saudi Arabia.… Continue Reading
Posts Tagged: Serbia
The World Bank’s enforcement arm, the Integrity Vice Presidency (INT), signaled this month they are mirroring initiatives first put forth by U.S. law enforcement. Specifically, INT indicated that they are investing significant resources into formally evaluating companies’ compliance programs during an investigation.… Continue Reading
Developing countries are losing between $20 billion to $40 billion every year, making graft the greatest obstacle to economic and social development around the world, according to a report released this month by the United Nations Office on Drugs and Crime (UNODC).… Continue Reading
A subsidiary of Pfizer Inc. agreed with the DOJ today to pay a $15 million criminal penalty to resolve FCPA violations in Bulgaria, Croatia, Kazakhstan, and Russia.
Pfizer also agreed with the SEC to pay $26.3 million in disgorgement of profits and pre-judgment interest to settle civil charges.… Continue Reading
U.K.-based pharma AstraZeneca said its office in Belgrade, Serbia was served with a criminal indictment ‘relating to allegations that local employees . . . made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.’ … Continue Reading